Amgen Archives - Pharmaphorum

Ready to pounce: Samsung joins Amgen with Humira biosimilar approval

August 25, 2017

No-one can launch biosimilars until patent expires next year

Ready to pounce: Samsung joins Amgen with Humira biosimilar approval

https://pharmaphorum.com/news/samsung-bioepis-humira-biosimilar-approved-eu/

Roche’s Herceptin facing further biosimilar threats in US

August 2, 2017

Breast cancer blockbuster facing potential trio of US competitors.

Roche’s Herceptin facing further biosimilar threats in US

https://pharmaphorum.com/news/roches-herceptin-facing-biosimilar-threats-us/

FDA rejects Amgen/UCB osteoporosis drug

July 17, 2017

The FDA has rejected Amgen and UCB’s Evenity (romosozumab) osteoporosis drug after a late-stage trial unexpectedly highlighted a

FDA rejects Amgen/UCB osteoporosis drug

https://pharmaphorum.com/news/fda-rejects-amgenucb-osteoporisis-drug/

Biosimilars manufacturers close in on Roche cancer blockbusters

July 14, 2017

FDA panel backs Herceptin and Avastin biosimilars.

Biosimilars manufacturers close in on Roche cancer blockbusters

https://pharmaphorum.com/news/biosimilars-herceptin/

Novartis CAR-T safety in FDA spotlight

July 11, 2017

FDA advisers are set to make recommendations on Novartis’ groundbreaking CAR-T therapy CTL019 tomorrow – and are set to

Novartis CAR-T safety in FDA spotlight

https://pharmaphorum.com/news/fda-advisers-consider-novartis-car-t-safety/

Alder shares slump despite migraine success

June 28, 2017

Investors concerned over strong placebo effect

Alder shares slump despite migraine success

https://pharmaphorum.com/news/alder-shares-slump-despite-migraine-success/

Novartis files migraine drug with EMA

June 21, 2017

Erenumab could be first new treatment in a decade.

Novartis files migraine drug with EMA

https://pharmaphorum.com/news/novartis-files-migraine-drug-ema/

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patients

June 11, 2017

Companies awaiting CV outcomes trial, and court decision in patent case

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patients

https://pharmaphorum.com/news/sanofiregeneron-pcsk9/

Teva on track to file migraine blockbuster

June 2, 2017

Phase 3 success for fremanezumab.

Teva on track to file migraine blockbuster

https://pharmaphorum.com/news/teva-track-file-migraine-blockbuster/

Trending

Amgen

Ready to pounce: Samsung joins Amgen with Humira biosimilar approval

Roche’s Herceptin facing further biosimilar threats in US

FDA rejects Amgen/UCB osteoporosis drug

Biosimilars manufacturers close in on Roche cancer blockbusters

Novartis CAR-T safety in FDA spotlight

Alder shares slump despite migraine success

Novartis files migraine drug with EMA

Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patients

Teva on track to file migraine blockbuster

CDD for Biologics Summit 2017

Neoantigen Summit 2017

ICI Summit Europe 2017

6th International GMP, GCP & Quality Control Summit

Inhalation and Respiratory Drug Products Summit

3rd Annual Pre-Filled Syringes Summit

Search

Advanced Search

Trending

Amgen